Texas Hemp Ban Lawsuit: Industry Legal Challenge and Policy Impact

Executive Summary

The Texas hemp industry filed a lawsuit in August 2026 challenging the state's ban on intoxicating hemp products, marking the most significant legal confrontation between commercial hemp interests and state regulators since the 2018 Farm Bill federally legalized hemp. The lawsuit, filed in Travis County District Court, argues that Texas exceeded its authority under both state and federal law when it enacted sweeping restrictions on delta-8 THC, THCA, and other hemp-derived cannabinoids. The litigation threatens to upend a regulatory framework affecting hundreds of Texas businesses and an estimated $500 million in annual hemp sales. At stake is whether states can effectively ban products derived from federally legal hemp, a question with implications extending far beyond Texas to the 15 other states that have enacted or proposed similar restrictions. The case arrives as the Drug Enforcement Administration considers rescheduling cannabis from Schedule I to Schedule III, potentially reshaping the entire legal landscape for both marijuana and hemp-derived products.

Why This Matters

The Texas hemp ban lawsuit affects an estimated 2,400 hemp retailers, 180 processors, and millions of consumers across the nation's second-largest state, with potential precedent-setting implications for hemp regulation nationwide. The economic stakes are substantial. Texas hemp businesses generated approximately $500 million in sales during 2025, according to industry estimates cited in the complaint. The ban threatens immediate closure for retailers whose inventory consists primarily of delta-8 THC products, THCA flower, and other hemp-derived intoxicants that proliferated after the 2018 Farm Bill created a legal pathway for hemp containing no more than 0.3% delta-9 THC by dry weight. Beyond Texas, the lawsuit matters because it tests fundamental questions about federalism and the Controlled Substances Act. The 2018 Farm Bill, codified at 7 U.S.C. § 1639o, explicitly removed hemp from the CSA's definition of marijuana, creating what the hemp industry argues is federal preemption of state attempts to re-criminalize hemp derivatives. Fifteen states including Arkansas, Colorado, Minnesota, Montana, New York, North Dakota, Oregon, Rhode Island, and Vermont have enacted varying restrictions on intoxicating hemp products, but none as comprehensive as Texas's approach. The litigation also affects consumer access to cannabinoid products in a state where marijuana remains fully illegal. For Texas residents seeking cannabinoid therapy for conditions ranging from chronic pain to anxiety, hemp-derived products represented the only legal option until the ban. An estimated 1.2 million Texas adults reported using hemp-derived cannabinoid products in 2025, according to survey data from the Texas Hemp Coalition, one of the plaintiff organizations. Medical patients face particular disruption. While Texas operates a limited Compassionate Use Program for low-THC cannabis, it restricts access to patients with specific qualifying conditions and caps THC content at 1% by weight. Hemp-derived THCA flower and delta-8 products filled gaps for patients who didn't qualify or couldn't afford the state's medical program, which serves only about 18,000 registered patients.

Background and History

The 2018 Farm Bill Opens the Hemp Floodgates

The Agriculture Improvement Act of 2018, signed December 20, 2018, removed hemp from the Controlled Substances Act and defined it as cannabis containing no more than 0.3% delta-9 THC on a dry weight basis. This single definitional change, codified at 7 U.S.C. § 1639o, created an unintended regulatory gap that entrepreneurs quickly exploited. The Farm Bill's authors focused primarily on industrial hemp applications—fiber, seed, and CBD extraction. Senator Mitch McConnell, the bill's primary champion, envisioned revitalizing Kentucky's agricultural economy through hemp cultivation for textiles and building materials. The legislation included no restrictions on processing hemp into derivative cannabinoids, and its narrow focus on delta-9 THC concentration left the door open for other intoxicating compounds.

Delta-8 THC Emerges as Legal Gray Area

By late 2019, chemists discovered they could convert CBD extracted from legal hemp into delta-8 THC through isomerization, creating an intoxicating product that arguably remained legal under the Farm Bill's definition. Delta-8 THC, a minor cannabinoid that occurs naturally in cannabis at concentrations below 1%, produces psychoactive effects similar to but reportedly milder than delta-9 THC. The conversion process involves dissolving CBD in a solvent, adding an acid catalyst, and applying heat to rearrange the molecular structure. The resulting delta-8 THC, when derived from hemp and present in a final product containing less than 0.3% delta-9 THC, appeared to satisfy the Farm Bill's requirements. Delta-8 products exploded across the United States in 2020 and 2021. Gas stations, smoke shops, and dedicated hemp retailers began selling delta-8 vapes, gummies, and tinctures. The market grew from essentially zero in 2019 to an estimated $2 billion nationally by 2022, according to data from the Hemp Industry Association.

Texas Hemp Industry Expands Rapidly

Texas became one of the nation's largest hemp markets between 2019 and 2025, with the Texas Department of Agriculture licensing 2,847 hemp growers and processors by December 2025. The state's agricultural infrastructure, favorable climate for outdoor cultivation, and large population created ideal conditions for hemp industry growth. The Texas Department of Agriculture, under Commissioner Sid Miller, adopted a permissive regulatory approach. The department's hemp program, approved by the U.S. Department of Agriculture in 2020, focused on ensuring crops tested below 0.3% delta-9 THC but imposed no restrictions on post-harvest processing or derivative products. Retail infrastructure grew even faster than cultivation. Hemp retailers opened in strip malls across Houston, Dallas, Austin, and San Antonio. By 2024, Texas had more hemp retail locations than liquor stores in several major metropolitan areas. Products ranged from CBD wellness items to high-potency delta-8 vapes and THCA flower marketed explicitly for its intoxicating effects.

THCA Flower Emerges as Hemp Loophole

Beginning in 2022, Texas hemp retailers began selling THCA-rich cannabis flower as a legal hemp product, exploiting the Farm Bill's focus on delta-9 THC concentration rather than total THC potential. THCA (tetrahydrocannabinolic acid) is the non-intoxicating precursor to delta-9 THC found in raw cannabis. When heated through smoking or vaping, THCA converts to delta-9 THC through decarboxylation. Cultivators bred high-THCA strains that tested below 0.3% delta-9 THC in their raw state but converted to 15-25% delta-9 THC when smoked—potency levels identical to marijuana sold in licensed dispensaries in states like California and Colorado. Retailers marketed these products as "legal weed" and "Texas cannabis," often displaying them in jars identical to those used in marijuana dispensaries. The THCA flower market grew rapidly in Texas. By 2025, an estimated 40% of Texas hemp retail revenue came from THCA flower sales, according to industry surveys. Popular strains included Wedding Cake, OG Kush, and Northern Lights—varieties identical to those sold as marijuana in other states.

Federal Regulatory Confusion

The Drug Enforcement Administration issued an Interim Final Rule in August 2020 stating that "all synthetically derived tetrahydrocannabinols remain schedule I controlled substances," creating ambiguity about delta-8 THC's legal status. The rule, published at 85 Fed. Reg. 51639, didn't explicitly address delta-8 or define "synthetically derived" with sufficient clarity to resolve the question. Hemp industry attorneys argued that delta-8 derived from hemp through isomerization wasn't "synthetic" because it involved converting one natural cannabinoid (CBD) into another (delta-8) that also occurs naturally in cannabis. The DEA never clarified the rule or took enforcement action against delta-8 products, creating a de facto legal market. The Food and Drug Administration similarly declined to regulate hemp-derived intoxicants aggressively. While the FDA maintained that adding CBD to food and beverages violated the Federal Food, Drug, and Cosmetic Act, it issued no warning letters specifically targeting delta-8 THC products and took no enforcement actions against THCA flower sales.

State-Level Backlash Begins

Between 2021 and 2025, fifteen states enacted restrictions on delta-8 THC and other intoxicating hemp derivatives, citing public health concerns and regulatory gaps. Alaska, Arizona, Arkansas, Colorado, Delaware, Kentucky, Montana, New York, North Dakota, Oregon, Rhode Island, Utah, Vermont, and Washington all passed varying levels of restrictions. Approaches varied significantly. Colorado integrated hemp-derived intoxicants into its existing marijuana regulatory framework, requiring testing and labeling but allowing licensed sales. New York banned delta-8 outright while permitting other hemp cannabinoids. Oregon required hemp processors to obtain marijuana licenses to produce intoxicating products. Texas initially resisted this trend. Commissioner Miller vocally supported the hemp industry and opposed restrictions. The Texas Legislature considered bills to regulate delta-8 during the 2021 and 2023 sessions but failed to pass comprehensive legislation.

Texas Reverses Course in 2026

On June 15, 2026, Texas Governor Greg Abbott signed House Bill 2119, banning the manufacture, distribution, and sale of "any hemp product intended for inhalation or ingestion that contains a total THC concentration exceeding 0.5 milligrams per serving or 2 milligrams per package." The legislation, which passed the Texas House 98-47 and the Senate 21-10, represented a dramatic reversal of the state's previous permissive approach. The bill's sponsors cited concerns about youth access, lack of testing requirements, and confusion between legal hemp products and illegal marijuana. Representative Tom Oliverson, the bill's House sponsor, said the legislation aimed to "close loopholes that have allowed intoxicating products to proliferate without any regulatory oversight" during floor debate on May 8, 2026. The legislation included several key provisions beyond the THC limits. It required all hemp products to undergo testing by ISO-certified laboratories, mandated child-resistant packaging, and prohibited marketing that appealed to minors. It also created a new licensing category for hemp retailers, with fees set at $1,500 annually. Critically, the law included no grandfather clause for existing inventory. Retailers had until August 1, 2026, to comply with the new restrictions, giving them just 45 days to liquidate inventory or face criminal penalties.

Industry Mobilizes Legal Challenge

On August 3, 2026, the Texas Hemp Coalition, Texas Hemp Growers Association, and twelve individual hemp businesses filed suit in Travis County District Court, seeking declaratory and injunctive relief against enforcement of HB 2119. The lawsuit, styled Texas Hemp Coalition et al. v. Texas Department of State Health Services et al., names the Department of State Health Services, the Texas Department of Agriculture, and Attorney General Ken Paxton as defendants. The complaint runs 87 pages and advances multiple legal theories. It argues HB 2119 violates the Supremacy Clause of the U.S. Constitution by attempting to regulate products that federal law explicitly legalized. It contends the law violates the Commerce Clause by discriminating against interstate commerce in hemp. It also raises state constitutional claims under the Texas Constitution's due process and takings clauses. The plaintiffs requested a temporary restraining order to halt enforcement pending resolution of the case. Travis County District Judge Jan Soifer scheduled a hearing on the TRO request for August 10, 2026.

Key Players

Texas Hemp Coalition

The Texas Hemp Coalition, founded in 2019, represents approximately 800 hemp businesses across Texas, including cultivators, processors, retailers, and ancillary service providers. The organization served as the primary industry voice during legislative debates over HB 2119, lobbying for amendments that would have preserved delta-8 and THCA products while implementing testing and age-verification requirements. Executive Director Lukas Gilkey, a former Texas Department of Agriculture official, leads the organization. The coalition maintains a political action committee that contributed $340,000 to Texas legislative candidates during the 2024 election cycle, according to Texas Ethics Commission filings.

Texas Hemp Growers Association

The Texas Hemp Growers Association represents the cultivation side of the industry, with 450 member farms spanning 28,000 licensed acres as of January 2026. The organization focuses primarily on agricultural policy but joined the lawsuit because HB 2119 effectively eliminates the market for high-THCA cultivars that many members had invested in growing. President Michael Bowman operates a 200-acre hemp farm in Bastrop County. According to the complaint, Bowman invested $180,000 in THCA genetics and cultivation infrastructure in 2025, anticipating continued legal sales.

Texas Department of State Health Services

The Texas Department of State Health Services assumed primary regulatory authority over hemp products under HB 2119, responsible for licensing retailers and enforcing the new THC limits. The department had not previously regulated hemp, which fell under the Texas Department of Agriculture's jurisdiction. DSHS Commissioner Jennifer Shuford testified in favor of HB 2119 during legislative hearings, citing concerns about emergency room visits related to delta-8 consumption. The department reported 347 calls to the Texas Poison Center related to delta-8 products in 2025, up from 89 in 2023.

Texas Department of Agriculture

The Texas Department of Agriculture, which administered the state's USDA-approved hemp program since 2020, opposed HB 2119 during the legislative process but is now tasked with enforcing cultivation-related provisions. Commissioner Sid Miller issued a statement on June 16, 2026, calling the new law "a devastating blow to Texas farmers who invested in a federally legal crop." The department licenses hemp growers under 4 Tex. Admin. Code § 24.1 et seq. and conducts pre-harvest testing to ensure compliance with the 0.3% delta-9 THC limit. Under HB 2119, the department must also verify that cultivators aren't growing high-THCA varieties intended for intoxicating use.

Attorney General Ken Paxton

Texas Attorney General Ken Paxton will defend the state against the lawsuit and oversee criminal enforcement of HB 2119 violations. Paxton's office issued an opinion in 2019 (Opinion No. KP-0257) concluding that delta-8 THC products were legal under Texas law following the 2018 Farm Bill, but the attorney general reversed that position during the 2026 legislative session. In a statement on June 15, 2026, Paxton said HB 2119 "protects Texas families from dangerous intoxicants that were never intended to be legal under federal hemp law."

Governor Greg Abbott

Governor Greg Abbott signed HB 2119 into law on June 15, 2026, after remaining largely silent on hemp policy during his first two terms. Abbott's office released a signing statement emphasizing the bill's public health protections and noting that "legitimate CBD and hemp fiber industries can continue to operate under sensible regulations." Abbott faces reelection in 2026 and received campaign contributions from both hemp industry supporters and law enforcement organizations that backed the ban.

Representative Tom Oliverson

Representative Tom Oliverson, an anesthesiologist from Houston, authored HB 2119 and led the legislative effort to restrict intoxicating hemp products. Oliverson chairs the House Public Health Committee and framed the legislation as addressing a public health crisis created by unregulated intoxicants. During floor debate, Oliverson said the bill aimed to "restore the original intent of hemp legalization, which was about industrial and wellness products, not getting high."

Senator Charles Perry

Senator Charles Perry sponsored the Senate companion bill and shepherded HB 2119 through the upper chamber. Perry, who represents a rural West Texas district with significant agricultural interests, initially opposed hemp restrictions but shifted position after meeting with law enforcement and medical professionals. Perry proposed an amendment that would have created a regulated market for delta-8 products similar to Colorado's approach, but it failed on a 15-16 vote.

Legal and Regulatory Framework

Federal Hemp Law: The 2018 Farm Bill

The Agriculture Improvement Act of 2018, codified at 7 U.S.C. § 1639o et seq., defines hemp as "the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis." This definition is critical to the lawsuit. The plaintiffs argue that by explicitly including "derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers," Congress intended to legalize all compounds derived from compliant hemp, including delta-8 THC and THCA. Section 297D of the Farm Bill, codified at 7 U.S.C. § 1639r, addresses state regulation of hemp. It provides that "a State or Indian Tribe may prohibit the production of hemp" within its jurisdiction but doesn't explicitly address whether states can ban hemp derivatives or finished products. The plaintiffs contend this silence, combined with the Supremacy Clause, preempts state attempts to re-criminalize federally legal hemp products.

The Controlled Substances Act

The Controlled Substances Act, 21 U.S.C. § 801 et seq., classifies marijuana as a Schedule I controlled substance under 21 U.S.C. § 812(c), but the 2018 Farm Bill amended the CSA's definition of marijuana to exclude hemp. Specifically, 21 U.S.C. § 802(16) now defines marijuana as "all parts of the plant Cannabis sativa L." except hemp as defined by 7 U.S.C. § 1639o. This creates the central legal question: if a product is derived from hemp and contains less than 0.3% delta-9 THC, is it categorically excluded from the CSA's marijuana definition, or can states regulate it as a controlled substance? The DEA's 2020 Interim Final Rule muddied these waters by stating that "all synthetically derived tetrahydrocannabinols remain schedule I controlled substances" (85 Fed. Reg. 51639). The rule didn't define "synthetically derived" or explicitly address delta-8 THC produced through isomerization of hemp-derived CBD.

Texas Controlled Substances Act

The Texas Controlled Substances Act, codified at Tex. Health & Safety Code § 481.001 et seq., previously defined marijuana to exclude hemp as defined by federal law. Section 481.002(26) defined marijuana as "the plant Cannabis sativa L., whether growing or not, the seeds of that plant, and every compound, manufacture, salt, derivative, mixture, or preparation of that plant or its seeds" but excluded "hemp, as that term is defined by Section 121.001, Agriculture Code." HB 2119 didn't amend the Controlled Substances Act directly. Instead, it added new Chapter 443 to the Texas Health and Safety Code, specifically regulating "consumable hemp products." This approach attempts to regulate hemp products through public health authority rather than controlled substances law.

HB 2119: Texas's Hemp Ban

House Bill 2119, codified at Tex. Health & Safety Code § 443.001 et seq., prohibits manufacturing, distributing, or selling "any hemp product intended for inhalation or ingestion that contains a total THC concentration exceeding 0.5 milligrams per serving or 2 milligrams per package." The law defines "total THC" as "the combined concentration of delta-9 tetrahydrocannabinol, delta-8 tetrahydrocannabinol, tetrahydrocannabinolic acid (THCA), and any other tetrahydrocannabinol isomer." This definition effectively bans delta-8 products and THCA flower while permitting low-dose CBD products. Key provisions include: Section 443.051 requires all hemp product manufacturers to obtain a license from DSHS, with fees set at $5,000 annually. Retailers must obtain a separate retail license at $1,500 annually. Section 443.101 mandates testing by ISO/IEC 17025-accredited laboratories for potency, pesticides, heavy metals, and microbial contaminants. Each batch must be tested, with results available to consumers via QR code. Section 443.151 requires child-resistant packaging for all consumable hemp products and prohibits packaging that appeals to minors. Section 443.201 creates criminal penalties for violations. Manufacturing or selling non-compliant products is a Class A misdemeanor for a first offense, punishable by up to one year in jail and a $4,000 fine. Subsequent offenses are state jail felonies. Section 443.251 includes a severability clause stating that if any provision is held invalid, the remaining provisions remain in effect.

Constitutional Claims in the Lawsuit

The plaintiffs' complaint advances four primary constitutional theories: Supremacy Clause preemption, Commerce Clause violations, due process violations, and unconstitutional takings. The Supremacy Clause argument, grounded in Article VI of the U.S. Constitution, contends that federal hemp law occupies the field and preempts state attempts to ban federally legal products. The complaint cites Crosby v. National Foreign Trade Council, 530 U.S. 363 (2000), for the proposition that state law is preempted when it "stands as an obstacle to the accomplishment and execution of the full purposes and objectives of Congress." The Commerce Clause claim argues that HB 2119 discriminates against interstate commerce by effectively prohibiting Texas businesses from purchasing hemp derivatives from out-of-state processors. The complaint cites Hunt v. Washington State Apple Advertising Commission, 432 U.S. 333 (1977), which struck down state regulations that discriminated against out-of-state products. The due process claim contends that HB 2119's 45-day implementation period denied businesses adequate time to liquidate inventory or adjust business models, violating the Fourteenth Amendment's Due Process Clause. The complaint notes that several plaintiffs invested hundreds of thousands of dollars in inventory that became worthless overnight. The takings claim argues that destroying the value of lawfully acquired inventory without compensation violates the Fifth Amendment's Takings Clause, applicable to states through the Fourteenth Amendment. The complaint cites Pennsylvania Coal Co. v. Mahon, 260 U.S. 393 (1922), for the principle that regulation can constitute a taking if it goes "too far."

State-by-State Breakdown of Hemp Restrictions

Alaska

Alaska banned delta-8 THC and other intoxicating hemp cannabinoids in 2021 through emergency regulations adopted by the Department of Environmental Conservation. Alaska Statute 17.38.900 now defines marijuana to include "any tetrahydrocannabinol, including delta-8 THC," regardless of source. Possession limits and regulations mirror those for marijuana. The state allows licensed marijuana retailers to sell delta-8 products if they comply with testing and packaging requirements applicable to marijuana.

Arizona

Arizona restricted delta-8 THC sales in 2021 by requiring products to be sold only through licensed marijuana dispensaries. The Arizona Department of Health Services issued guidance stating that delta-8 THC is an "artificial marijuana" under A.R.S. § 13-3401 and subject to the same regulations as marijuana. Hemp-derived CBD products remain legal if they contain no more than 0.3% total THC.

Arkansas

Arkansas banned delta-8 THC and THCA products in 2021 through Act 629, which amended the state's definition of marijuana to include all THC isomers. Arkansas Code § 5-64-101 now defines marijuana to include "all parts of the plant Cannabis sativa L." and "every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin, including tetrahydrocannabinol (THC) and all other cannabinol derivatives, including its naturally occurring or synthetically produced ingredients."

Colorado

Colorado integrated hemp-derived intoxicants into its regulated marijuana market through HB 21-1317, enacted in 2021. The law requires hemp processors who produce intoxicating products to obtain marijuana licenses and comply with testing, packaging, and labeling requirements under the Colorado Marijuana Code. Products must be sold through licensed dispensaries. Total THC limits are set at 50 milligrams per package for edibles. The approach allows continued sales while ensuring regulatory oversight.

Delaware

Delaware banned delta-8 THC in 2022 through HB 371, which added delta-8 and other THC isomers to the state's list of Schedule I controlled substances. Delaware Code Title 16, § 4716 now includes "tetrahydrocannabinols, including delta-8 THC, delta-10 THC, and any other THC isomer" as controlled substances. Possession is a misdemeanor punishable by up to six months imprisonment.

Kentucky

Kentucky banned delta-8 THC in 2023 through HB 777, despite being the home state of Senate Minority Leader Mitch McConnell, the Farm Bill's primary sponsor. Kentucky Revised Statute § 218A.010 now defines marijuana to include "all tetrahydrocannabinol isomers, including delta-8 THC, delta-10 THC, and THCA." The law includes an exception for hemp-derived CBD products containing less than 0.3% total THC.

Montana

Montana restricted intoxicating hemp products in 2021 through SB 358, which requires products containing more than 0.3% total THC to be sold through licensed marijuana dispensaries. Montana Code § 50-46-302 defines "adult-use marijuana" to include hemp-derived products that exceed the 0.3% threshold when total THC is calculated. The law effectively bans delta-8 and THCA products from hemp retailers while allowing sales through the regulated marijuana market.

New York

New York banned delta-8 THC in 2022 through emergency regulations issued by the Office of Cannabis Management. The regulations, codified at 9 NYCRR § 114, prohibit manufacturing, distributing, or selling "any cannabinoid product containing delta-8 THC or other intoxicating cannabinoids derived from hemp." The state cited concerns about unregulated production and lack of testing. CBD products remain legal if they contain no detectable THC.

North Dakota

North Dakota banned delta-8 THC and THCA in 2021 through HB 1045, which amended the state's controlled substances schedule. North Dakota Century Code § 19-03.1-01 now defines marijuana to include "all tetrahydrocannabinol isomers and their salts, including delta-8 THC, delta-10 THC, THCA, and any other intoxicating cannabinoid." The law includes no exception for hemp-derived products.

Oregon

Oregon requires hemp processors who produce intoxicating products to obtain marijuana licenses under HB 3000, enacted in 2021. Oregon Revised Statute § 475C.009 defines "adult use cannabis item" to include "any hemp product or hemp extract that has been processed in a manner that increases the total THC concentration to a level that would cause impairment." Processors must comply with testing, packaging, and labeling requirements under the Oregon Liquor and Cannabis Commission's regulations.

Rhode Island

Rhode Island banned delta-8 THC in 2022 through regulations adopted by the Department of Business Regulation. Rhode Island General Law § 21-28.6-3 now prohibits "any hemp-derived product containing delta-8 THC, delta-10 THC, or other intoxicating cannabinoids in concentrations exceeding 0.3% by dry weight." The state allows licensed marijuana retailers to sell delta-8 products if they comply with marijuana regulations.

Utah

Utah banned delta-8 THC in 2022 through HB 227, which added delta-8 and other THC isomers to the state's controlled substances schedule. Utah Code § 58-37-4 now classifies "any tetrahydrocannabinol isomer, including delta-8 THC, delta-10 THC, and THCA" as Schedule I controlled substances. The law includes an exception for hemp-derived CBD products containing less than 0.3% total THC.

Vermont

Vermont restricted intoxicating hemp products in 2022 through Act 164, which requires products containing more than 1 milligram of total THC per serving to be sold through licensed marijuana retailers. Vermont Statute Title 7, § 861 defines "regulated hemp product" as any hemp product intended for ingestion or inhalation that contains more than the threshold amount. The law allows continued sales through regulated channels while prohibiting sales in gas stations and convenience stores.

Washington

Washington banned delta-8 THC in 2022 through emergency regulations adopted by the Liquor and Cannabis Board. Washington Administrative Code § 314-55-077 prohibits "any hemp product containing artificially derived cannabinoids, including delta-8 THC, delta-10 THC, and THC-O." The state defines "artificially derived" to include cannabinoids produced through isomerization or chemical synthesis. Licensed marijuana retailers may sell delta-8 products if they comply with marijuana testing and packaging requirements.

Market and Business Implications

Immediate Economic Impact on Texas Hemp Industry

The Texas hemp ban threatens to eliminate an estimated $500 million in annual sales and force closure of approximately 40% of the state's 2,400 hemp retail locations. According to economic impact data cited in the lawsuit, the Texas hemp industry employed 8,700 people as of June 2026, with average wages of $42,000 annually. The ban puts approximately 3,500 jobs at immediate risk. Retailers face the most severe impact. Businesses that specialized in delta-8 and THCA products—representing an estimated 60% of Texas hemp retailers—have no compliant products to sell under the new law. The 45-day implementation period left insufficient time to pivot to alternative product lines or liquidate inventory at anything approaching wholesale cost. Several retailers interviewed for the complaint reported selling THCA flower inventory at 10-20 cents on the dollar to out-of-state buyers in states without bans. Others reported destroying inventory rather than risk criminal penalties for possession after August 1, 2026.

Wholesale Market Disruption

Texas hemp processors and distributors face collapse of their primary revenue streams, with wholesale delta-8 distillate prices dropping from $1,200 per kilogram in May 2026 to $200 per kilogram by late July as processors liquidated inventory. The wholesale market for THCA biomass similarly collapsed. High-THCA flower that traded at $400-600 per pound in early 2026 became effectively worthless in Texas, though some processors shipped inventory to states without bans. Transportation presented legal risks, as interstate shipment of THCA flower arguably violates federal law if the product is intended for intoxicating use. Extraction laboratories that specialized in converting CBD to delta-8 face existential threats. The complaint identifies three Texas laboratories that collectively invested $4.2 million in specialized equipment for delta-8 production. That equipment has no alternative use under the new regulatory framework.

Impact on Hemp Cultivation

Texas hemp farmers who invested in high-THCA genetics face total loss of their 2026 crop, with an estimated 4,200 acres of THCA-rich hemp planted before HB 2119 passed. Unlike delta-8 processors who can potentially sell inventory out of state, farmers face immediate destruction of crops that won't mature until September and October 2026. The Texas Department of Agriculture has indicated it will require destruction of high-THCA crops, even though the plants test below 0.3% delta-9 THC in their pre-harvest state and technically comply with federal hemp law. Farmers who planted in April and May 2026, before HB 2119 passed, face losses ranging from $15,000 to $80,000 per acre depending on planting density and cultivation method. The ban also affects farmers who grew hemp